Sign in
4

Changes in Ownership

IRulya Therapeutics Inc. Filed Acc 0001209191-20-063277

Executive Vice President acquired 3,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Holsinger Leslie Executive Vice President 2020-12-10 Option exercise +3,500 $0.27 $945 3,500 D
Derivatives
Holsinger Leslie Executive Vice President 2020-12-10 Option exercise · Stock Option (Right to Buy) −3,500 106,794 D
Loading xslF345X03/doc4.xml…